Stada Seeking OTC Acquisitions After Strong 2018 As Private-Equity Owners Begin To Flex Muscles
Germany's Stada is on the look out for consumer health acquisitions globally that can help it reach its ambition to grow faster than the market in 2019. The firm's new private-equity owners are backing CEO Peter Goldschmidt's plan to take the Branded Products division to the next level.
You may also be interested in...
Stada Plots Eastern European Expansion With Walmark Deal
Stada is set to snap up Czech Republic-based Walmark in its second major deal this year as it looks to make good on its promise to rapidly expand its OTC-focused Branded Products business.
Stada ‘Continuously Evaluating’ OTC Deals As Sales Grow Double Digits
Stada tells HBW Insight it remains on the lookout for deals despite only last month closing the acquisition of a basket of OTC brands from GSK. The German firm revealed its plans as it reported a double-digit rise in both sales and earnings at its Branded Products business for the opening six months of 2019.
Stada Reveals Skin-Care Ambitions With Acquisition Of GSK Brands
Stada has snapped up a basket of OTC skin-care brands from GSK, with CEO Peter Goldschmidt telling HBW Insight that the category is a "key focus" for the Germany-based firm.